Blood Products Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
Standard testing for human immunodeficiency virus variants is among the topics planned for discussion by the panel at a June 19 meeting in Rockville, Maryland. For additional information, contact Linda Smallwood at 301/827-3514 or FDA's information line at 800/741-8131 and use code 19516...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.